Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Wegovy does not cause withdrawal in the way that stopping certain medications — like opioids or benzodiazepines — does. Semaglutide is not physically addictive. But coming off it does change how your body regulates appetite and blood sugar, and those changes can feel significant. Understanding what to expect, and what your real decision is here, makes a meaningful difference. These are prescription-only medicines; any plan to stop, pause or restart should go through your prescriber rather than something you navigate alone. The semaglutide overview covers the broader picture of how the medicine works if you want that context first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The word "withdrawal" gets attached to a lot of experiences with semaglutide, but it covers several quite different things. True pharmacological withdrawal, as clinicians define it, means physical dependence: the body has adapted to the drug's presence and reacts when it disappears. That does not happen with semaglutide. There is no GLP-1 receptor dependence in that sense.
What people describe as withdrawals from Wegovy usually falls into one of three categories. The first is the return of appetite, sometimes dramatically so, because semaglutide suppresses hunger quite powerfully and its absence is noticeable. The second is GI symptoms: some people experience nausea, loose stools or digestive discomfort in the first days after their last dose, likely because the gut adapts to the slower gastric emptying the medicine creates and then readjusts. These are real and can be uncomfortable; they are not a sign something is seriously wrong. The third category is psychological: food noise, cravings and the mental weight of managing appetite without pharmaceutical support can feel like a different kind of hardship.
None of this means stopping is straightforward. It just means the framing matters. If you are searching for information about wegovy withdrawal symptoms, you are probably trying to decide whether to stop, how to stop, or whether what you are experiencing right now is normal. Those are the questions worth addressing.
The evidence on stopping semaglutide is fairly consistent. The STEP 1 trial, published in the New England Journal of Medicine, followed participants for a further year after they stopped active treatment. Weight regain was substantial: on average, participants regained around two-thirds of the weight they had lost within twelve months of stopping. Cardiometabolic markers (blood pressure, blood sugar, cholesterol) also drifted back toward baseline.
This is not a failure of the person. Semaglutide works by suppressing appetite via GLP-1 receptors; when the drug clears, those receptors go back to their baseline state, and hunger regulation reverts. The medicine treats a chronic condition. Stopping it without other strategies in place means the condition continues. That is why many clinicians frame GLP-1 medicines the way they frame blood pressure treatment: stopping is a clinical decision, not simply a lifestyle one.
Gastrointestinal symptoms after stopping, including gas with Wegovy that some people notice as their digestion readjusts, generally resolve within a week or two. They can feel like can you get withdrawals from semaglutide territory, but they are transient gut-readjustment rather than dependence. The NHS medicines page for semaglutide is a reliable reference for what side effects look like in both directions.
There are legitimate reasons to stop Wegovy, side effects that have not settled, a planned pregnancy, a change in health circumstances, or simply a personal choice. There are also reasons to continue that are easy to underestimate: the weight-management benefits, reduced cardiovascular risk in eligible patients, and the difficulty of maintaining results without the medicine.
Your prescriber weighs up the whole picture: how much weight you have lost, how long you have been on treatment, whether you have weight-related conditions that were improving, and whether a structured stop (rather than simply missing doses) is advisable. At nume, every repeat order is clinically re-reviewed; that process also gives you a natural point to raise doubts, concerns or a wish to stop. You can also read through our FAQs or contact the aftercare team through the contact page if you have a specific question before your next review.
One practical habit worth building into any review: check your pen before your next scheduled dose day. A quick look at whether it is stored correctly (refrigerated, not frozen, not near the fridge door's warm zone) rules out one source of unexpected symptoms that gets misread as the medicine's effect wearing off. Worth thirty seconds.
Restarting after a break is possible, but your prescriber will reassess you rather than simply resuming at the dose you were on. The reason is clinical caution: a significant gap means your tolerance to the medication has reduced, and restarting at a high dose raises the risk of side effects. This is not a bureaucratic hurdle; it protects you.
If cost has been a factor in stopping, it is worth reading the honest breakdown on Wegovy prices in the UK, understanding what is and is not included in different providers' quotes sometimes changes the calculation. Some people also find they have been paying for a service that does not include the aftercare support that makes treatment sustainable.
If you are weighing up whether Wegovy is still the right choice, or have practical questions such as whether you can fly with Wegovy during a break in treatment, the weight-loss treatment overview covers the options licensed in the UK. And if you want to speak with a prescriber directly, starting a free consultation is the straightforward next step. A real clinician reads your answers the same day (not an automated system) and the conversation is under no pressure.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.